Prostaglandin E2 (PGE2) from glioma cells was observed to boost the production of IL-10 by DCs, resulting in the development of a regulatory response in CD4 T cells and a reduction in effector lymphocyte stimulation [143]. The gene discussed is CD4; the disease is central nervous system cancer.